Literature DB >> 16817738

Comparison of the biological activity of recombinant human thyroid-stimulating hormone with bovine thyroid-stimulating hormone and evaluation of recombinant human thyroid-stimulating hormone in healthy dogs of different breeds.

Felicitas S Boretti1, Nadja S Sieber-Ruckstuhl, Barbara Willi, Hans Lutz, Regina Hofmann-Lehmann, Claudia E Reusch.   

Abstract

OBJECTIVE: To evaluate whether use of recombinant human (rh) thyroid-stimulating hormone (TSH) induces equivalent stimulation, compared with bovine TSH (bTSH), and to evaluate activity of rhTSH in dogs of various large breeds. ANIMALS: 18 healthy research Beagles and 20 healthy client-owned dogs of various breeds with body weight > 20 kg. PROCEDURES: The 18 Beagles were randomly assigned to 3 groups, and each dog received either 75 microg of rhTSH, IM or IV, or 1 unit of bTSH, IM, respectively, in a crossover design. The 20 client-owned dogs received 75 microg of rhTSH, IV. Blood samples were taken before and 6 hours after TSH administration for determination of total serum thyroxine (T(4)) concentration. Additional blood samples were taken after 2 and 4 hours in Beagles that received rhTSH, IM.
RESULTS: There was a significant increase in T(4) concentration in all dogs, but there were no differences between values obtained after administration of bTSH versus rhTSH or IV versus IM administration of rhTSH. Although there was a significant difference in age and body weight between Beagles and non-Beagles, there was no difference in post-TSH simulation T(4) concentration between the 2 groups. CONCLUSIONS AND CLINICAL RELEVANCE: Results indicated an equivalent biological activity of rhTSH, compared with bTSH. Use of 75 microg of rhTSH, IV, did not induce a different magnitude of stimulation in large-breed dogs, compared with Beagles. Euthyroidism was confirmed if post-TSH simulation T(4) concentration was > or = 2.5 microg/dL and at least 1.5 times basal T(4) concentration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817738     DOI: 10.2460/ajvr.67.7.1169

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  2 in total

1.  Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content.

Authors:  Sandra Schaefer; Paul O Hassa; Nadja S Sieber-Ruckstuhl; Marion Piechotta; Claudia E Reusch; Bernd Roschitzki; Felicitas S Boretti
Journal:  BMC Vet Res       Date:  2013-07-16       Impact factor: 2.741

2.  The role of hypothyroidism in the etiology and progression of dilated cardiomyopathy in Doberman Pinschers.

Authors:  P Beier; S Reese; P J Holler; J Simak; G Tater; G Wess
Journal:  J Vet Intern Med       Date:  2014-10-10       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.